Global Influenza Diagnostic Market Strategies 2024, Forecast To 2033

12 Jan, 2024

The influenza diagnostic market has seen strong growth, escalating from $2.59 billion in 2023 to $2.79 billion in 2024, with a 7.6% CAGR. Historical growth drivers include public health concerns, technological advancements, antiviral medications, and pandemic preparedness. The forecast anticipates continued strong growth, reaching $3.68 billion in 2028, with a 7.2% CAGR. Ongoing factors include seasonal influenza, point-of-care testing, remote and home testing, and digital health integration.

Global Influenza Diagnostic Market Key Driver

Rapid diagnostic tests propel the influenza diagnostic market. Rapid influenza diagnostic tests detect viral antigens in 10-15 minutes with moderate sensitivity. CDC data reveals a 0.2% positive rate for influenza in U.S. clinical laboratories during September 2020 to May 2021, indicating the impact of rapid diagnostic tests.

Get A Free Sample Of The Global Influenza Diagnostic Market Report

Global Influenza Diagnostic Market Segments

The influenza diagnostic market covered in this report is segmented –
1)By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2)By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3)By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users
By Geography: The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Major Influenza Diagnostic Industry Players

F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

Get The Full Global Influenza Diagnostic Market Report

Influenza Diagnostic Market Overview

Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

Influenza Diagnostic Global Market Report 2023 provides data on the global influenza diagnostic market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The influenza diagnostic market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.